Stocks · News reference
Acumen Pharmaceuticals Reports Cash Balance Of $110.2M As Of June 30, 2026, Expected to Cash Runway Into Early 2027
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 12, 2026, 11:10 AM
- Checked
- Aug 12, 2026, 11:10 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Acumen Pharmaceuticals, Inc. (ABOS)
Filed: 2026-08-12 AccNo: 0001628280-26-055940 Size: 8 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarAcumen Pharmaceuticals shares are trading lower. The company highlighted enhanced brain delivery program data and early Alzheimer’s disease insights at Alzheimer’s AAIC 2026.
Read original at benzinga